[1] |
国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识. 中国防痨杂志, 2020,42(4):301-307.
|
[2] |
周新华, 陈步东, 吕岩 , 等. 非活动性肺结核的影像学评价. 中国防痨杂志, 2018,40(3):251-254.
|
[3] |
Linguissi LS, Vouvoungui CJ, Poulain P , et al. Diagnosis of smear-negative pulmonary tuberculosis based on clinical signs in the Republic of Congo. BMC Res Notes, 2015,8:804.
|
[4] |
Goletti D, Lindestam AC, Scriba TJ , et al. Can we predict tuberculosis cure? What tools are available? Eur Respir J, 2018, 52(5). pii: 1801089.
|
[5] |
吕纯芳, 吴健虹, 卢留珠 , 等. 国产实时荧光定量PCR试剂与GeneXpert MTB/RIF检测结核分枝杆菌的对比分析. 中国防痨杂志, 2020,42(1):60-65.
|
[6] |
Friedrich SO, Rachow A, Saathoff E , et al. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med, 2013,1(6):462-470.
|
[7] |
欧喜超, 董海燕, 夏辉 , 等. 交叉引物恒温扩增检测技术在疑似肺结核患者临床诊断中的价值. 中国防痨杂志, 2018,40(10):1040-1045.
|
[8] |
Honeyborne I, Mtafya B, Phillips PP , et al. The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment. J Clin Microbiol, 2014,52(8):3064-3067.
|
[9] |
全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508.
|
[10] |
Wang F, Yu J, Zhou Y , et al. The Use of TB-Specific Antigen/Phytohemagglutinin Ratio for Diagnosis and Treatment Monitoring of Extrapulmonary Tuberculosis. Front Immunol, 2018,9:1047.
|
[11] |
Ahmed MM, Ntinginya NE, Kibiki G , et al. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy. Front Immunol, 2018,9:2247.
doi: 10.3389/fimmu.2018.02247
URL
|
[12] |
李芳, 贺伟, 周新华 , 等. 非结核分枝杆菌肺病和活动性肺结核的高分辨率CT表现异同性分析. 中国防痨杂志, 2018,40(5):499-505.
|
[13] |
Malherbe ST, Shenai S, Ronacher K , et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med, 2016,22(10):1094-1100.
doi: 10.1038/nm.4177
URL
|
[14] |
许岩, 路希维, 蔡春葵 , 等. 治疗失败耐多药肺结核患者CT征象演变的回顾性分析. 中国防痨杂志, 2020,42(6):549-557.
|
[15] |
Cadosch D, Abel Zur Wiesch P, Kouyos R et al. The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB. PLoS Comput Biol, 2016,12(3):e1004749.
doi: 10.1371/journal.pcbi.1004749
URL
|
[16] |
Ravimohan S, Kornfeld H, Weissman D , et al. Tuberculosis and Lung Damage: From Epidemiology to Pathophysiology. Eur Respir Rev, 2018, 27(147). pii: 170077.
|
[17] |
World Health Organization. Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB Xpert MTB/Rif Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children. Geneva: World Health Organization, 2013.
|
[18] |
World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRA) in low- and middle-income countries. Geneva: World Health Organization, 2011.
|
[19] |
World Health Organization. The Use of Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for the Diagnosis and Screening of Active Tuberculosis in People Living with Hiv Policy Guidance. Geneva: World Health Organization, 2015.
|
[20] |
World Health Organization. The Use of Molecular Line Probe Assays for the Detection of Resistance to Second-Line Anti-Tuberculosis Drugs Policy Guidance. Geneva: World Health Organization, 2016.
|
[21] |
Lewinsohn DM, Leonard MK, Lobue PA , et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis, 2017,64(2):e1-33.
doi: 10.1093/cid/ciw694
URL
|
[22] |
肖和平, 方勇 . 多学科协作开启结核病防治新时代. 中华结核和呼吸杂志, 2017,40(5):321-322.
|